Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The White House strategy embraces syringe services, access to housing and naloxone as three science-based approaches.
COVID-19 had an “immense impact” on HIV, hepatitis and STI screening, prevention and care.
Now that the dam has broken, it may not be long before additional overdose prevention centers open around the country.
Over 94,000 people died of drug overdoses in the U.S. last year. New York activists urge the new governor to OK overdose prevention centers.
This California county had the highest hepatitis C rates in the state, and yet officials have hampered syringe programs.
A new CDC model shows the potential power of Undetectable = Untransmittable to curb HIV rates by 2027.
A revamped National Harm Reduction Coalition tackles the “racist war on drugs” and advocates for people who use drugs.
We’ve reported on STI clinics closing, but harm reduction advocates are also raising alarms—and trying to reach those most vulnerable.
A survey of local health departments reveals concerning news—and a silver lining.
In that state, and across the nation, accidental overdose is the leading cause of death for people under 50.
Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.
New cases of all three viruses have declined in the city over the past decade.
An analysis of newly diagnosed youths in California found they had limited access to opioid-related harm reduction services.
A new study confirms that providing clean drug injection equipment slows the spread of HIV.
Judge’s ruling may pave the way for opening the nation’s first supervised overdose prevention facility.
Two new interactive (and free!) databases offer maps, policies and much more, courtesy of amfAR.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.